cancer

For more cancer news, visit the Vanderbilt-Ingram Cancer Center website »

December 18, 2013

Targeting tumor “supply lines”

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.

By Leigh MacMillan
Stomach
September 26, 2013

Cell changes en route to stomach cancer

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer.

By Leigh MacMillan
Campus aerials. (John Russell/Vanderbilt University)
September 20, 2013

Live Facebook chat on hereditary cancer risk

Join an upcoming live Facebook Chat in which Vanderbilt-Ingram Cancer Center experts will answer your questions about hereditary cancer risk on Sept. 24 at 6 p.m.

By VUMC News and Communications
September 19, 2013

VU study brings genome’s ‘dark matter’ into light

Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer.

By Bill Snyder
September 18, 2013

Fishing for new anti-cancer drugs

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

By Leigh MacMillan
September 13, 2013

Cancer nanomedicines on target

Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time.

By Leigh MacMillan
September 12, 2013

VU study identifies DNA changes in drug-resistant cancer cells

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
By Leigh MacMillan
July 29, 2013

Motor protein revs up cell division

A motor protein that helps drive cell division may be a promising new target for cancer therapeutics.
By Leigh MacMillan
June 10, 2013

Factor’s yin-yang tumor effects

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor.
By Leigh MacMillan
June 6, 2013

Leukemia & Lymphoma Society honors Ohi’s research

Puck Ohi, Ph.D., assistant professor of Cell and Developmental Biology, has received the Leukemia & Lymphoma Society SCHOLAR award for his research on the role of enzymes that affect cell division, which has implications for treating cancer and blood disorders like leukemia and lymphoma.
By VUMC News and Communications
May 21, 2013

West Tennessee Healthcare and Vanderbilt University Medical Center announce academic affiliation agreement

By VUMC News and Communications
April 4, 2013

Cancer studies reveal new genetic variants

The future of cancer is becoming clearer. And it’s not looking so good for cancer.
By Bill Snyder
April 1, 2013

Fingers and toes: joint forming factor

The gene Has2 participates in signaling that is important in developing fingers and toes, and may have relevance for cancer development.
By Leigh MacMillan
1 … 11 12 13 14 15 … 23